Aft Forsyth & Sober’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.99M Hold
3,250
0.91% 34
2025
Q4
$3.49M Hold
3,250
1.06% 29
2025
Q3
$2.48M Hold
3,250
0.77% 34
2025
Q2
$2.53M Buy
3,250
+2,200
+210% +$1.71M 0.85% 32
2025
Q1
$867K Hold
1,050
0.3% 64
2024
Q4
$811K Buy
+1,050
New +$869K 0.26% 70

Other funds holding LLY

Aft Forsyth & Sober's LLY Position: Q1 2026 in Review

Aft Forsyth & Sober held its Eli Lilly (LLY) position steady in Q1 2026 at 3,250 shares worth $2.99M. The position accounts for 0.91% of the portfolio, ranked #34.

Aft Forsyth & Sober first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.49M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Aft Forsyth & Sober held 3,250 shares of Eli Lilly worth $2.99M as of Q1 2026.
  • Aft Forsyth & Sober left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.91% of Aft Forsyth & Sober's portfolio in Q1 2026, its #34 holding.
  • Aft Forsyth & Sober first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Aft Forsyth & Sober's Eli Lilly position peaked at $3.49M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Aft Forsyth & Sober's 13F filing for Q1 2026, filed 14 May 2026.